Rituximab depletion of intrahepatic B cells to control refractory hepatic autoimmune overlap syndrome

QJM. 2019 Oct 1;112(10):793-795. doi: 10.1093/qjmed/hcz161.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Alanine Transaminase / metabolism
  • Alkaline Phosphatase / metabolism
  • B-Lymphocytes / drug effects*
  • Drug Administration Schedule
  • Drug Resistance
  • Female
  • Hepatitis, Autoimmune / prevention & control*
  • Humans
  • Immunoglobulin G / metabolism
  • Immunoglobulin M / metabolism
  • Immunologic Factors / administration & dosage*
  • Immunotherapy / methods
  • Infusions, Intravenous
  • Liver Cirrhosis / prevention & control
  • Lymphocyte Subsets
  • Middle Aged
  • Rituximab / administration & dosage*
  • Syndrome
  • Treatment Outcome

Substances

  • Immunoglobulin G
  • Immunoglobulin M
  • Immunologic Factors
  • Rituximab
  • Alanine Transaminase
  • Alkaline Phosphatase